or Try an Advanced Search...

    Investigational Stocks List

    Symbol Grade Name % Change
    BCDA F BioCardia, Inc. 1.31
    BIOR F Biora Therapeutics, Inc. 2.55
    DCTH B Delcath Systems, Inc. 2.21
    DVAX D Dynavax Technologies Corporation 0.17
    ESTA B Establishment Labs Holdings Inc. 6.73
    GLPG F Galapagos NV -1.22
    MIRM D Mirum Pharmaceuticals, Inc. 0.94
    MTEM F Molecular Templates, Inc. -3.19
    NAVB F Navidea Biopharmaceuticals, Inc. 9.14
    NERV F Minerva Neurosciences, Inc 0.85
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Medicine Acid Biology Biopharmaceutical Biotechnology Clinical Development Hepatology Inflammatory Diseases Melanoma Oncology Parkinson's Disease Abdominal Pain Aesthetics Aging Associated Diseases Alzheimer's Disease Antidepressants Arthritis Asthma Autoimmune And Inflammatory Disease Autoimmune Disease

    Related ETFs - A few ETFs which own one or more of the above listed Investigational stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 3.83
    PBE C PowerShares Dynamic Biotech & Genome 2.62
    SBIO D ALPS Medical Breakthroughs ETF 2.03
    IDNA C iShares Genomics Immunology and Healthcare ETF 1.91
    XBI D SPDR S&P Biotech ETF 1.8
    View all Investigational ETFs...
    Compare ETFs
    Compare IDNA to XBI Compare PBE to IDNA Compare SBIO to XBI

        Investigational Stocks Recent News

        Date Stock Title
        May 2 GLPG Galapagos reports Q1 results
        May 2 GLPG Galapagos reports first quarter 2024 financial results
        May 2 MIRM Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
        May 2 ESTA Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
        May 1 GLPG Galapagos Q1 2024 Earnings Preview
        May 1 MIRM Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
        May 1 ESTA Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
        May 1 NERV Minerva Neurosciences GAAP EPS of -$1.13
        May 1 NERV Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
        May 1 BCDA BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
        Apr 30 GLPG Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
        Apr 30 MIRM Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
        Apr 30 BIOR Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Medicine Acid Biology Biopharmaceutical Biotechnology Clinical Development Hepatology Inflammatory Diseases Melanoma Oncology Parkinson's Disease Abdominal Pain Aesthetics Aging Associated Diseases Alzheimer's Disease Antidepressants Arthritis Asthma Autoimmune And Inflammatory Disease Autoimmune Disease
        Investigational

        Browse All Tags